However, due to elevated liver enzymes seen in patients taking the drug during testing, Pfizer said it decided to shed the lotiglipron program and move forward with its twice-daily GLP-1 pill
When food enters the gastrointestinal tract, GLP-1 is released into the bloodstream in response to nutrient intake, particularly carbohydrates and fats
Additional reasons for deferral include: Diabetes-related complications affecting the heart, kidneys, eyes, peripheral nerves, or circulation Recent hospital admission or significant illness Unstable diabetes control or recent treatment changes Concurrent serious medical conditions Donors must also meet standard eligibility criteria regarding age (17 years or older
Available online at: (Accessed January 20, 2026)
Arrival in Uyuni
Together, these effects reduce food cravings, slow gastric emptying, and regulate blood sugar